Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study

Baptiste Pignon,Joane Matta,Emmanuel Wiernik,Anne Toussaint,Bernd Loewe,Olivier Robineau,Fabrice Carrat,Gianluca Severi,Mathilde Touvier,Clement Gouraud,Charles Ouazana Vedrines,Victor Pitron,Brigitte Ranque,Nicolas Hoertel,Sofiane Kab,Marcel Goldberg,Marie Zins,Cédric Lemogne
DOI: https://doi.org/10.1136/bmjment-2023-300907
2024-03-16
Evidence-Based Mental Health
Abstract:Background Identifying factors that predict the course of persistent symptoms that occurred during the COVID-19 pandemic is a public health issue. Modifiable factors could be targeted in therapeutic interventions. Objective This prospective study based on the population-based CONSTANCES cohort examined whether the psychological burden associated with incident persistent symptoms (ie, that first occurred from March 2020) would predict having ≥1 persistent symptom 6–10 months later. Methods A total of 8424 participants (mean age=54.6 years (SD=12.6), 57.2% women) having ≥1 incident persistent symptom at baseline (ie, between December 2020 and February 2021) were included. The psychological burden associated with these persistent symptoms was assessed with the Somatic Symptom Disorder-B Criteria Scale (SSD-12). The outcome was having ≥1 persistent symptom at follow-up. Adjusted binary logistic regression models examined the association between the SSD-12 score and the outcome. Findings At follow-up, 1124 participants (13.3%) still had ≥1 persistent symptom. The SSD-12 score at baseline was associated with persistent symptoms at follow-up in both participants with (OR (95% CI) for one IQR increase: 1.42 (1.09 to 1.84)) and without SARS-CoV-2 infection prior to baseline (1.39 (1.25 to 1.55)). Female gender, older age, poorer self-rated health and infection prior to baseline were also associated with persistent symptoms at follow-up. Conclusions The psychological burden associated with persistent symptoms at baseline predicted the presence of ≥1 persistent symptom at follow-up regardless of infection prior to baseline. Clinical implications Intervention studies should test whether reducing the psychological burden associated with persistent symptoms could improve the course of these symptoms.
psychiatry
What problem does this paper attempt to address?
The problem that this paper attempts to solve is whether the identification of the psychological burden associated with persistent symptoms that emerged during the COVID - 19 pandemic can predict the persistence of these symptoms 6 - 10 months later. Specifically, the study aims to explore the following points: 1. **Relationship between psychological burden and persistent symptoms**: The study mainly focuses on whether the psychological burden of persistent symptoms that emerged in the early stage of the pandemic (i.e., symptoms that first appeared since March 2020) can predict the persistence of these symptoms 6 - 10 months later. 2. **Influence of infection status**: The study also explores whether the relationship between this psychological burden and persistent symptoms is affected by the SARS - CoV - 2 infection status, that is, whether the psychological burden can predict the existence of persistent symptoms regardless of whether the participants were infected with SARS - CoV - 2 before the baseline. 3. **Other relevant factors**: The study also analyzes the influence of factors such as gender, age, and self - assessed health status on persistent symptoms. Through these analyses, the study hopes to provide a basis for clinical interventions, especially whether reducing the psychological burden associated with persistent symptoms can improve the course of these symptoms.